Lourdes Cucurull-Sanchez joins Pharmetheus as Scientific Lead for the Quantative Systems Pharmacology (QSP) platform

She brings extensive experience from several positions from large companies within drug development, and has made strong scientific contributions through her work within clinical pharmacology. The addition strengthens the company’s focus on QSP, ensuring continued innovation and latest expertise.

CAR-T cell therapy is part of the next generation of immuno-oncology treatment

It was Anna’s passion and expertise in these novel therapeutic modalities like CAR-T cells that led her to her current position at Pharmetheus. She can be considered one of the few experts in the field of CAR-T cell modeling, and her review paper “Model-informed drug development of autologous CAR-T cell therapy: Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modeling” was one of the most downloaded papers last year.

Education for empowerment: Online training in Clinical Pharmacology and Pharmacometrics in French

In a global landscape where language can serve as a barrier to knowledge acquisition, the need for scientific learning material in French is pivotal in many African countries. Pharmetheus’ consultants, primarily those who contributed to the French translation of Pharmacometrics Africa’s Pharmacometrics Self-paced online course, feature as guest speakers.

Pharmetheus evolves its organization to further promote innovation and growth with additions to its leadership team

Pharmetheus announces an evolved organizational structure with additions in the leadership team, and expands business development to further promote innovation and growth.